Developing explanatory models for life course shifts in the burden of substance use to inform future policy and practice.
Drugs
Life course
Midlife
Mortality
Overdose
Journal
The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
26
03
2020
revised:
23
09
2020
accepted:
17
02
2021
pubmed:
10
3
2021
medline:
14
9
2021
entrez:
9
3
2021
Statut:
ppublish
Résumé
Past approaches to policy and practice for substance use have focused heavily on young people, but recent trends indicate this approach may not be where the future lies. The crises with escalating overdose mortality in several countries, particularly overdoses related to opioids, have drawn attention to life course shifts in the burdens of substance use. Overdose mortality rates for individuals in midlife have considerably outpaced those of adolescents and individuals in early adulthood. These diverging life course trends are occurring not only in the United States, but in other countries with growing overdose problems as well. The future of effective policy and practice depend upon evidence and analyses that adapt to emerging data on shifting life course trends in drug related mortality. Within this manuscript, we consider a range of theoretical possibilities on the divergence of midlife drug mortality trends from those of young people for the purpose of outlining an agenda for future research and practice. Specifically, we consider the following theoretical approaches to move research forward in this area: Changes in Medical Context hypothesis; Emergent Comorbidities hypothesis; Cohort hypothesis; Generational Forgetting hypothesis; Legal Regulation hypothesis; Strength of Life Course Bonds hypothesis; Deepening Inequality hypothesis; Measurement Reliability hypothesis. These theoretical frameworks attend specifically to the overdose crisis but extend to other aspects of substance use. Beyond setting an agenda for research by providing empirically verifiable hypotheses, this manuscript also identifies future directions in policy and practice that are attentive to life course trends.
Identifiants
pubmed: 33685803
pii: S0955-3959(21)00080-3
doi: 10.1016/j.drugpo.2021.103182
pmc: PMC9632333
mid: NIHMS1844705
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
103182Subventions
Organisme : NIDA NIH HHS
ID : R21 DA046447
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declarations of Interest Regarding the paper “Developing Explanatory Models for Life Course Shifts in the Burden of Substance Use to Inform Future Policy and Practice” recently submitted to the International Journal of Drug Policy, the authors – Brian C Kelly and Mike Vuolo – have no actual or potential conflicts of interest to report. We have no financial, personal or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, this work.
Références
Psychol Rev. 1993 Oct;100(4):674-701
pubmed: 8255953
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15078-83
pubmed: 26575631
Annu Rev Law Soc Sci. 2017 Oct;13(1):181-202
pubmed: 34045931
Int J Drug Policy. 2016 Jun;32:11-6
pubmed: 27198555
Soc Sci Med. 2007 Nov;65(9):1965-78
pubmed: 17618718
Psychol Med. 2011 Jul;41(7):1365-72
pubmed: 21144109
Pain Pract. 2008 Nov-Dec;8(6):417-22
pubmed: 18662363
Pediatrics. 2018 Mar;141(3):
pubmed: 29483198
Med Sci Law. 2006 Jan;46(1):81-4
pubmed: 16454466
Addiction. 2003 Mar;98(3):305-15
pubmed: 12603230
Virtual Mentor. 2013 Nov 01;15(11):960-5
pubmed: 24257088
Soc Sci Med. 2015 Mar;128:316-26
pubmed: 25577953
Sociol Health Illn. 2017 Mar;39(3):333-348
pubmed: 27594300
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Drug Alcohol Depend. 2014 Sep 1;142:350-3
pubmed: 25042761
Sociol Forum (Randolph N J). 2010 Dec 1;25(4):787-803
pubmed: 21359092
Pers Soc Psychol Rev. 2012 Aug;16(3):203-32
pubmed: 22194251
Drug Alcohol Depend. 2013 Nov 1;133(1):212-21
pubmed: 23726978
Lancet Public Health. 2017 May 10;2(6):e267-e276
pubmed: 28626829
Addiction. 2011 Oct;106(10):1790-800
pubmed: 21545669
Demogr Res. 2018;38(66):2073-2086
pubmed: 31592199
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Am J Prev Med. 2015 Mar;48(3):326-33
pubmed: 25498551
Health Aff (Millwood). 1991 Spring;10(1):140-54
pubmed: 2045046
Soc Sci Med. 2006 Apr;62(7):1768-84
pubmed: 16226363
Soc Sci Med. 2009 Aug;69(3):327-34
pubmed: 19552992
JAMA. 2012 Mar 7;307(9):913-4
pubmed: 22396509
Addict Behav. 2009 Mar;34(3):258-63
pubmed: 19008050
Addiction. 2019 Feb;114(2):248-258
pubmed: 30207015
Drug Alcohol Depend. 2012 Aug 1;124(3):259-67
pubmed: 22361212
Science. 2018 Sep 21;361(6408):
pubmed: 30237320
J Res Crime Delinq. 2014 Nov 1;51(6):735-758
pubmed: 25484453
Soc Sci Med. 2017 Oct;190:174-180
pubmed: 28865253
Drug Alcohol Depend. 1996 Dec 11;43(3):143-53
pubmed: 9023070
Int J Drug Policy. 2011 Jul;22(4):285-91
pubmed: 21700441
Drug Alcohol Rev. 2011 Jul;30(4):397-402
pubmed: 21355898
J Psychoactive Drugs. 1999 Oct-Dec;31(4):423-33
pubmed: 10681109
Demography. 2006 Nov;43(4):691-710
pubmed: 17236542
JAMA. 2011 Apr 6;305(13):1315-21
pubmed: 21467284
J Health Soc Behav. 2018 Dec;59(4):487-500
pubmed: 30229682
Int J Drug Policy. 2019 Sep;71:183-188
pubmed: 30718120
Thorax. 2008 Oct;63(10):925-31
pubmed: 18820119
Clin Pharmacol Ther. 2017 Feb;101(2):209-219
pubmed: 28019026
Drug Alcohol Depend. 2003 May 21;70(2):139-48
pubmed: 12732407
Drug Alcohol Rev. 2010 Jul;29(4):352-7
pubmed: 20636649
J Health Soc Behav. 2001 Mar;42(1):1-16
pubmed: 11357716
Am J Public Health. 2004 Jan;94(1):96-102
pubmed: 14713705
Soc Sci Med. 1994 Jan;38(1):1-14
pubmed: 8146699
Dev Psychol. 2012 Nov;48(6):1759-73
pubmed: 22059449
Pediatrics. 2017 Dec;140(6):
pubmed: 29109106
Addiction. 1999 Jul;94(7):961-72
pubmed: 10707430